vimarsana.com
Home
Live Updates
TissueCypher® Barrett's Esophagus Test Outperformed Sta
TissueCypher® Barrett's Esophagus Test Outperformed Sta
TissueCypher® Barrett's Esophagus Test Outperformed Standard of Care in Risk-Stratifying Patients with Barrett's Esophagus
The study, published in Gastroenterology, shows TissueCypher can increase the detection of Barrett’s esophagus patients with an initial diagnosis of low-grade dysplasia who will progress to...
Related Keywords
Amsterdam ,
Noord Holland ,
Netherlands ,
Jacques Bergman ,
Castle Biosciences ,
Nasdaq ,
University Of Amsterdam ,
Facebook ,
Amsterdam University Medical Centers ,
Castle Biosciences Inc ,
Securities Exchange ,
Instagram ,
Linkedin ,
Centers For Medicare Medicaid Services ,
Laboratory Test ,
Artificial Intelligence ,
Radiofrequency Ablation ,
Tissuecypher Barrett ,
Advanced Diagnostic Laboratory Test ,
Medicaid Services ,
Mypath Melanoma ,
Securities Act ,
Securities Exchange Act ,
Annual Report ,
Markets ,